Growth factor production in human endothelial cells after Chlamydia pneumoniae infection

International Journal of Medical Microbiology

Volumn 294, Issue 1, 2004, Pages 53-57

  Prochnau, Dirk ^a   Rödel, Jürgen ^a   Hartmann, Matthias ^a   Straube, Eberhard ^a   Figulla, Hans Reiner ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Atherosclerosis; bFGF; Chlamydia pneumoniae; Endothelial cells; PDGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTERIAL INFECTION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; HEAT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INFECTION; INOCULATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; ULTRAVIOLET RADIATION;

EID: 3142704258     PISSN: 14384221     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijmm.2003.11.001     Document Type: Article

References (12)

1. Coombes, B.K., Mahony, J.B., 1999. Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). Infect. Immun. 67, 2909-2915.
2. Coombes, B.K., Mahony, J.B., 2001. cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect. Immun. 69, 1420-1427.
3. Coombes, B.K., Chiu, B., Fong, I.W., Mahony, J.B., 2002. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis. J. Infect. Dis. 185, 1621-1630.
4. Ferns, G.A.A., Raines, E.W., Sprugel, K.H., Montani, A.S., Reidy, M.A., Ross, R., 1991. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129-1132.
5. Grayston, J.T., 2000. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J. Infect. Dis. 181, 402-410.
6. Ngeh, J., Anand, V., Gupta, S., 2002. Chlamydia pneumoniae and atherosclerosis - what we know and what we don't. Clin. Microbiol. Infect, 8, 2-13.
7. Reidy, M.A., 1994. Growth factors and arterial smooth muscle cell proliferation. Ann. NY Acad. Sci. 714, 225-230.
8. Rödel, J., Woytas, M., Groh, A., Schmidt, K.H., Hartmann, M., Lehmann, M., Straube, E., 2000. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect. Immun. 68, 3635-3641.
9. Ross, R., 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-146.
10. Ross, R., Glomset, J.A., 1973. Atherosclerosis and the arterial smooth muscle cell. Science 180, 1332-1339.
11. Ueda, M., Becker, A.E., Kasyuki, N., Kojima, A., Morita, Y., Tanaka, S., 1996. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am. J. Pathol. 149, 831-843.
12. Yazdani, S., Simon, A.D., Vidhun, R., Gulotta, C., Schwartz, A., Rabbani, L.E., 1998. Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions. Am. Heart. J. 136, 357-361.